EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lung Carcinoids: A Comprehensive Review for Clinicians

Dan Granberg iD, Carl Christofer Juhlin iD, Henrik Falhammar iD, Elham Hedayati iD

Cancers · 16.11.2023 · 15 (22) · 5440

DOI: 10.3390/cancers15225440 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 16.11.2023. Verfasst von Dan Granberg und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine and Surgery, Karolinska Institutet, 17176 Stockholm, Sweden. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung carcinoids are neuroendocrine tumors, categorized as typical or atypical carcinoids based on their histological appearance. While most of these tumors are slow-growing neoplasms, they still possess malignant potential. Many patients are diagnosed incidentally on chest X-rays or CT scans. Presenting symptoms include cough, hemoptysis, wheezing, dyspnea, and recurrent pneumonia. Endocrine symptoms, such as carcinoid syndrome or ectopic Cushing’s syndrome, are rare. Surgery is the primary treatment and should be considered in all patients with localized disease, even when thoracic lymph node metastases are present. Patients with distant metastases may be treated with somatostatin analogues, chemotherapy, preferably temozolomide-based, mTOR inhibitors, or peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE. Most patients have an excellent prognosis. Poor prognostic factors include atypical histology and lymph node metastases at diagnosis. Long-term follow-up is mandatory since metastases may occur late.

Schlagwörter

Stichwörter der Autor:innen

diagnosislung carcinoidsprognosissymptomstreatment

Autor:innen und Institutionen

  • Department of Molecular Medicine and Surgery, Karolinska Institutet, 17176 Stockholm, Sweden.
  • Department of Breast, Endocrine Tumors and Sarcomas, Karolinska University Hospital Solna, 17176 Stockholm, Sweden.
  • Department of Oncology-Pathology, Karolinska Institutet, 17164 Stockholm, Sweden.
  • Department of Pathology and Cancer Diagnostics, Karolinska University Hospital Solna, 17176 Stockholm, Sweden.
  • Department of Endocrinology, Karolinska University Hospital Solna, 17176 Stockholm, Sweden.

ORCID-Profile: Dan Granberg, Carl Christofer Juhlin, Henrik Falhammar, Elham Hedayati

Zitieren

APA

Granberg, D., Juhlin, C. C., Falhammar, H., & Hedayati, E. (2023). Lung Carcinoids: A Comprehensive Review for Clinicians. Cancers, 15(22), 5440. https://doi.org/10.3390/cancers15225440

Vancouver

Granberg D, Juhlin CC, Falhammar H, Hedayati E. Lung Carcinoids: A Comprehensive Review for Clinicians. Cancers. 2023;15(22):5440. doi:10.3390/cancers15225440

BibTeX
@article{Granberg2023,
  author = {Granberg, Dan and Juhlin, Carl Christofer and Falhammar, Henrik and Hedayati, Elham},
  title = {Lung Carcinoids: A Comprehensive Review for Clinicians},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {22},
  pages = {5440},
  doi = {10.3390/cancers15225440}
}
Kostenlos starten →